Assessment Of The Anti-Diabetic Activicty Of Schefflera Stellata Leaves Ethanolic Extract On Streptozotocin-Induced Diabetes In Wistar Rats
Main Article Content
Abstract
Diabetes mellitus is a chronic metabolic disorder characterized by elevated blood glucose levels, affecting millions of people worldwide. This study aimed to evaluate the potential anti-diabetic activity of Schefflera stellata leaves ethanolic extract in a streptozotocin (STZ)-induced diabetic Wistar rat model. Wistar rats were induced with diabetes using STZ and subsequently treated with Schefflera stellata leaves ethanolic extract. Various biochemical parameters such as fasting blood glucose levels, serum insulin levels, lipid profile, and antioxidant enzyme activities were assessed. Additionally, histopathological examination of pancreatic tissues was performed to evaluate the impact of the extract on structural alterations. The results revealed a significant reduction in fasting blood glucose levels in rats treated with Schefflera stellata extract compared to the untreated diabetic group. Moreover, the extract exhibited a positive influence on serum insulin levels, lipid profile, and antioxidant enzyme activities, suggesting its potential in ameliorating diabetes-induced metabolic dysregulation. Histopathological analysis of pancreatic tissues indicated a preservation of islet architecture in the extract-treated group, highlighting the protective effects of Schefflera stellata against STZ-induced pancreatic damage.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Halim M, Halim A. The effects of inflammation, aging and oxidative stress on the pathogenesis of diabetes mellitus (type 2 diabetes). Diabetes & metabolic syndrome. Clinical Research & Reviews. 2019 Mar 1;13(2):1165-72.
Khan MY, Gupta P, Bihari B,Verma VK. A review on diabetes and it's management. Asian Journal of Pharmceutical Research.2013;3(1):27-32.
Chatterjee T, Sahu PK, Chatterjee s, Godheja J. Current and future biotechnological approaches for diabetes mellitus. Asian journal of pharmacy and technology.2011;1(4):94-98.
Manik S, Gautam V, Kalia AN: Anti-diabetic and antihyperlipedemic effect of allopolyherbal formulation in OGTT and STZ induced diabetic rat model. Indian Journal of Experimental Biology. 2013; 51: 702-8.
Kirana H, Srinivasan BP: Effect of Cyclea peltata Lam rootsaqueous extract on glucose levels, lipid profile, insulin, TNF α and skeletal muscle glycogen in type 2 diabetic rats. Indian journal of Experimental Biology2010; 48: 499-02.
Zhang D, Xie T, Leung PS. Irisin ameliorates glucolipotoxicity-associated β-cell dysfunction and apoptosis via AMPK signaling and anti-inflammatory actions. Cellular Physiology and Biochemistry. 2018;51(2):924-37.
Dimri S, Tiwari P, Basu S, Parmar VR. Drug use pattern in children at a teaching hospital. Indian Pediatrics. 2009;46(2):165-167.
Mogensen C, Christensen C. Predicting diabetic nephropathy in insulin dependent diabetics. New England Journal of Medicine 1984;311:89-93
DCCT (Diabetes Control and Complications Trial) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin- dependent diabetes mellitus. New England Journal of Medicine 1993;329:977-989.
DeFronzo RA. From the triumvirate to the ominous octet: A new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 2009;58:773-95.
Babin D Reejo, P. Natarajan, A. Thangathirupathi. Evaluation Of Antidiabetic Activity Of Samanea Saman (Jacq.) Merr International Journal Of Research In Pharmaceutical And Nano Sciences. 3(4), 2014, 352- 356.
Raman N. Phytochemical Technique. 2006; New Indian Publishing Agencies: New Delhi p.19.
Egon Stahl, “Thin Layer Chromatography”, A Laboratory Handbook, 2nd Edition, Springer Publication, 1996; 694: 1-8.
Kumar A et al. Anti-diabetic activity of Syzygium cumini and its isolated compound against streptozotocin-induced diabetic rats. Journal of Medicinal Plants Research 2008; 2(9): 246-249.